Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Hepatology (Baltimore, Md.)|February 26, 2026
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world studyFrancesco Tovoli, Massimo Iavarone, Giuseppe Cabibbo, et al.
Cancers|February 6, 2021
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCsBrian I Carr, Vito Guerra, Rossella Donghia, et al.
The International Journal of Biological Markers|March 1, 2021
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameterBrian I Carr, Vito Guerra, Rossella Donghia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 11, 2018
Metabolic disorders across hepatocellular carcinoma in ItalyFilomena Morisco, Maria Guarino, Maria R Valvano, et al.
Drugs in Context|January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice studyRodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environmentAlessandro Cucchetti, Annagiulia Gramenzi, Philip Johnson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Sara Labanca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Cancers|June 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score AnalysisRodolfo Sacco, Edoardo G Giannini, Raffaella Tortora, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|February 26, 2026
Long-term outcomes of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A real-world studyFrancesco Tovoli, Massimo Iavarone, Giuseppe Cabibbo, et al.
Cancers|February 6, 2021
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCsBrian I Carr, Vito Guerra, Rossella Donghia, et al.
The International Journal of Biological Markers|March 1, 2021
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameterBrian I Carr, Vito Guerra, Rossella Donghia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 11, 2018
Metabolic disorders across hepatocellular carcinoma in ItalyFilomena Morisco, Maria Guarino, Maria R Valvano, et al.
Drugs in Context|January 7, 2021
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice studyRodolfo Sacco, Vincenzo Messina, Umberto Vespasiani Gentilucci, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2021
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environmentAlessandro Cucchetti, Annagiulia Gramenzi, Philip Johnson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2016
The evolutionary scenario of hepatocellular carcinoma in Italy: an updateLaura Bucci, Francesca Garuti, Barbara Lenzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 31, 2022
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinomaEdoardo G Giannini, Giulia Pieri, Sara Labanca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resectionFilippo Pelizzaro, Franco Trevisani, Vittorio Simeon, et al.
Cancers|June 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score AnalysisRodolfo Sacco, Edoardo G Giannini, Raffaella Tortora, et al.
Pageof 17